BindingDB logo
myBDB logout

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
31352245 6 Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.EBI Medical School of Nanjing University
30384044 4 Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.EBI University of Sassari
26787274 40 Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors.EBI Institute of Technology & Science-Pilani
26678175 26 Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? Mycobacterium tuberculosis novel bacterial topoisomerase inhibitors.EBI Birla Institute of Technology & Science-Pilani
23294829 14 Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.EBI Universit£
18426901 8 Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.EBI Universit£
30122228 6 Design, synthesis and antibacterial properties of pyrimido[4,5-b]indol-8-amine inhibitors of DNA gyrase.EBI Redx Pharma
30097361 5 A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity.EBI Csir-Central Institute of Medicinal and Aromatic Plants (Csir-Cimap)